Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
3(60%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
1
20%
Ph early_phase_1
1
20%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution2 total trials
Early Phase 1First-in-human
1(50.0%)
Phase 4Post-market surveillance
1(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

5

all time

Status Distribution
Active(3)
Completed(2)

Detailed Status

Recruiting3
Completed2

Development Timeline

Analytics

Development Status

Total Trials
5
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (50.0%)
Phase 41 (50.0%)

Trials by Status

recruiting360%
completed240%

Recent Activity

3 active trials
Showing 5 of 5
recruitingphase_4

Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide

NCT06657209
recruiting

The Physiology of Human Brown Adipose Tissue

NCT04352244
recruiting

Exercise Response in Humans With Obesity

NCT05857150
completedearly_phase_1

Cold Induced Changes in White Adipose

NCT02596776
completed

Pilot Study for Noninvasive Spectroscopic Detection of Adipose Tissue Inflammation in Obesity

NCT01900366

Clinical Trials (5)

Showing 5 of 5 trials
NCT06657209Phase 4

Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide

Recruiting
NCT04352244

The Physiology of Human Brown Adipose Tissue

Recruiting
NCT05857150

Exercise Response in Humans With Obesity

Recruiting
NCT02596776Early Phase 1

Cold Induced Changes in White Adipose

Completed
NCT01900366

Pilot Study for Noninvasive Spectroscopic Detection of Adipose Tissue Inflammation in Obesity

Completed

All 5 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
5